About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Dallas | 13,796 Studies Near You

Clinical TrialsDallas

Clinical Trials in Dallas

Discover 13,796 clinical trials near Dallas, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1481-1500 of 13,796 trials

Active not recruitingBlinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic LeukemiaThis phase II trial studies the side effects and how well blinatumomab and combination chemotherapy or dasatinib, prednisone, and blinatumomab work in treating older patients with…NCT02143414·Birmingham, Alabama and 194 others

Find Trials by Condition in Dallas

Breast Cancerin Dallas Lung Cancerin Dallas Prostate Cancerin Dallas Colorectal Cancerin Dallas Melanomain Dallas Leukemiain Dallas Lymphomain Dallas Pancreatic Cancerin Dallas Ovarian Cancerin Dallas Brain Cancerin Dallas Diabetesin Dallas

Data from ClinicalTrials.govTerms

RecruitingMocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCTThis is a multi-center, randomized, double-blinded, placebo controlled trial.NCT05429632·Birmingham, Alabama and 110 others

Active not recruitingStudy Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)This is a Phase 1/2, open-label, multicenter study to determine the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory CLL or SLL.NCT03331198·Birmingham, Alabama and 83 others

CompletedStudy of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque PsoriasisThe purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days.NCT01714544·Cincinnati, Ohio and 4 others

Active not recruitingA Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid TumorsThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07220060 and PF-07104091) in people with breast cancer.NCT05262400·Los Angeles, California and 43 others

Active not recruitingWATER IV Prostate CancerThis is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk…NCT06651632·Chandler, Arizona and 36 others

CompletedA Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney DiseaseResearchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD).NCT05047263·Huntsville, Alabama and 325 others

CompletedStudy of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic MigraineMigraine is characterized by attacks of throbbing, moderate or severe headache, often associated with nausea, vomiting, and/or sensitivity to light and/or sound.NCT05216263·Hoover, Alabama and 28 others

TerminatedA Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular CarcinomaThis study will evaluate the safety, tolerability, DLTs, MTD, and preliminary anti tumor activity of tivozanib in combination with durvalumab in subjects with advanced HCC.NCT03970616·Gilbert, Arizona and 9 others

CompletedSafety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative ColitisThis study is a prospective clinical study to evaluate the safety and efficacy of two different doses of Asacol for the treatment of moderately active ulcerative colitis.NCT00073021·Scottsdale, Arizona and 56 others

CompletedA Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung CancerThe primary purpose of this study is to determine the 2-year survival rate of both of the chemotherapy regimens in patients with inoperable non-small-cell lung cancer.NCT00482014·Los Angeles, California and 10 others

CompletedTreatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)This study is to determine the recommended phase II dose (RP2D) and schedule of CX-4945 when administered orally twice daily for 28 consecutive days, in a 4-week (28 days) cycle…NCT03897036·Scottsdale, Arizona and 5 others

UnknownMonoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and ChemotherapyRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00003634·Berkeley, California and 45 others

CompletedEfficacy and Safety of TAK-442 in Subjects Undergoing Total Knee ReplacementThe purpose of this study is to determine if TAK-442, once daily (QD) or twice daily (BID), is as safe and effective as enoxaparin in preventing the development of blood clots…NCT00641732·Birmingham, Alabama and 63 others

Active not recruitingSparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental GlomerulosclerosisTo evaluate the safety and efficacy of sparsentan tablets for the treatment of patients with proteinuria after kidney transplantation with once-daily dosing for 36 weeks.NCT07219121·Birmingham, Alabama and 7 others

CompletedSafety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy, safety and tolerability of vortioxetine, once daily (QD), compared with placebo in adults with major depressive disorder.NCT01179516·Little Rock, Arkansas and 60 others

TerminatedSafety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only SubjectsOpen-label, randomized, controlled, phase 3 safety and efficacy registration trial.NCT03393000·Irvine, California and 12 others

RecruitingStudy of Cabozantinib With Selumetinib for Plexiform NeurofibromasBased on the clinical activity of both selumetinib and cabozantinib as monotherapies in clinical trials, the demonstrated activity of these agents in reduced doses in preclinical…NCT06502171·Birmingham, Alabama and 7 others

CompletedNT-101 Topical Ophthalmic Solution in Patients With Wet AMDPhase 1/2 Trial NT-101 Topical Ophthalmic Solution in Patients with Wet Age-Related Macular Degeneration (AMD)NCT06704009·Rosedale, Maryland and 3 others

CompletedBootcamp During Neoadjuvant Chemotherapy for Breast CancerThis is a randomized, single-site pilot study incorporating one control group. This research involves an exercise group and a non-exercise group (control group).NCT01411787·Dallas, Texas

PreviousPage 75 of 690Next

Heart Diseasein Dallas